SynthesisFrontiers in immunology2024

Efficacy and safety of transarterial chemoembolization plus lenvatinib combined with PD-1 inhibitors versus transarterial chemoembolization plus lenvatinib for unresectable hepatocellular carcinoma: a meta-analysis.

Yue Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.